Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
A*STAR, NHCS, NUS, and Novo Nordisk partner to study the mechanisms underlying heart failure

A*STAR, NHCS, NUS, and Novo Nordisk partner to study the mechanisms underlying heart failure

bit.bio launches Huntington’s disease human cell model

bit.bio launches Huntington’s disease human cell model

New model can predict drug-drug interactions based on drug-induced gene expression signatures

New model can predict drug-drug interactions based on drug-induced gene expression signatures

Discovery could lead to new treatments to minimize cravings in people with addictions

Discovery could lead to new treatments to minimize cravings in people with addictions

MIT researchers develop a smarter method to discover new drugs

MIT researchers develop a smarter method to discover new drugs

Cancer Research UK reveals innovation engine underpinned by £400m portfolio of cutting-edge discovery science

Cancer Research UK reveals innovation engine underpinned by £400m portfolio of cutting-edge discovery science

UNIGE scientists develop a novel tool to visualize palmitoylation process in living cells

UNIGE scientists develop a novel tool to visualize palmitoylation process in living cells

Dotmatics, previously Insightful Science, set to transform the future of scientific software and data management

Dotmatics, previously Insightful Science, set to transform the future of scientific software and data management

Dotphoton and Hamamatsu Photonics are partnering to provide the ultimate raw image compression and address the ever-growing biomedical image data volume

Dotphoton and Hamamatsu Photonics are partnering to provide the ultimate raw image compression and address the ever-growing biomedical image data volume

CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

Sample management specialists win Queen’s Award for Enterprise

Sample management specialists win Queen’s Award for Enterprise

Reaction Biology's Novel Approach to Oncology Drug Discovery at AACR Showcase

Reaction Biology's Novel Approach to Oncology Drug Discovery at AACR Showcase

Epigenetics likely to be the reason why lung cancer patients develop treatment resistance

Epigenetics likely to be the reason why lung cancer patients develop treatment resistance

Nemours Children’s Health scientists receive two NIH grants to advance pediatric cancer research

Nemours Children’s Health scientists receive two NIH grants to advance pediatric cancer research

Venomtech announces new drug development collaboration with Charles River

Venomtech announces new drug development collaboration with Charles River

Nanocell COVID-19 vaccine elicits potent neutralizing response

Nanocell COVID-19 vaccine elicits potent neutralizing response

A novel PLpro inhibitor as a broad-spectrum anti-coronavirus agent

A novel PLpro inhibitor as a broad-spectrum anti-coronavirus agent

ADDF supports the need to gather more evidence about clinical effectiveness of anti-amyloid drug

ADDF supports the need to gather more evidence about clinical effectiveness of anti-amyloid drug